Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers

PURPOSE: Cisplatin resistance is a major concern in ovarian cancer treatment. The aim of this study was to investigate if wedelolactone could perform better in resistant ovarian cancer cells when used in combination with cisplatin. METHODS: Growth inhibitory potential of wedelolactone and cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarwar, Sadia, Alamro, Abir A, Alghamdi, Amani A, Naeem, Komal, Ullah, Salamat, Arif, Muazzam, Yu, Jun Qing, Huq, Fazlul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164677/
https://www.ncbi.nlm.nih.gov/pubmed/34079223
http://dx.doi.org/10.2147/DDDT.S288707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164677/
https://www.ncbi.nlm.nih.gov/pubmed/34079223
http://dx.doi.org/10.2147/DDDT.S288707

Ejemplares similares